Psychedelics trials ramp up despite TGA decision
PERTH: Australian psychedelic drug experiments will continue despite the Therapeutic Goods Administration rejecting ... read more
ResMed ready to capitalise on ‘foot fault’ by rival Philips
MELBOURNE: ResMed boss Mick Farrell says the company can secure long-term market share ... read more
Health booking platform 1st Group to buy telehealth firm
MELBOURNE: Telehealth solutions provider Visionflex has signed a deal to merge with ASX-listed ... read more
